Contact Information
Company Information
Company
Orna Therapeutics, Inc.
Annual Revenue
38500000.0
Total Funding
321000000.0
Technologies
Mimecast
Outlook
Vimeo
Mobile Friendly
Nginx
WordPress.org
Google Tag Manager
Typekit
Render
Remote
Keywords
biotechnology research
rna therapeutics
circular rna
lnp delivery
gene editing
oncology
autoimmune diseases
in vivo car therapy
scd treatment
beta-thalassemia
gene therapy
crispr genome editing
therapeutic proteins
rna medicine
pancar
lipid nanoparticles
immune system targeting
hspc delivery
car-t therapies
novel vaccine candidates
dna delivery systems
pharmaceutical development
biotech innovations
therapeutics pipeline
mrna alternatives
disease treatment
molecular engineering
clinical stage products
drug discovery
biopharmaceuticals
biotechnology
genetic diseases
non-viral delivery
hsc-targeted therapies
high throughput screening
reliable dose control
disease management
therapeutic applications
protein expression enhancement
patient care advancements
medicinal chemistry
biologics manufacturing
rna engineering
molecular virology
immunology research
pharmaceutical partnerships
biotech venture capital
clinical research
native immune response
medical devices
emerging technologies
orna
targeted delivery
infectious diseases
genetic disorders
pancar technology
therapeutic innovation
healthcare professionals
pharmaceutical companies
strategic partnerships
clinical studies
patient care
advanced therapeutics
healthcare solutions
disease modification
protein expression
simplified production
off-the-shelf treatments
market segmentation
healthcare industry
life sciences
research & development
patient outcomes
transformative medicine
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans